Revvity (NYSE: RVTY) surged past fourth-quarter expectations and issued an upbeat 2026 outlook, driven by robust demand in its diagnostics division. The medical equipment maker's performance highlights a sector-wide resilience despite ongoing softness in academic research funding.
A convoy of Syrian government forces was observed moving toward the strategic northeastern city of Hasakah on Monday, implementing a ceasefire agreement that aims to reintegrate Kurdish-administered territories with Damascus.
A British Columbia court has given its final approval to Coeur Mining's planned acquisition of New Gold, moving the deal that will create a North American precious metals giant one step closer to its expected H1 2026 closing.
Chinese biotech firm Arctic Vision moves to create an integrated ophthalmology powerhouse by acquiring MDCO Technology's device business, combining drug and device expertise to address unmet needs in eye care.
Truist Securities raises its price target on Huntington Bancshares (HBAN) following a robust Q4 performance, as the regional bank forecasts record interest income growth and benefits from improving industry tailwinds.
Amid a mixed market landscape, corporate insiders are placing significant bets on select small-cap stocks. We analyze three companies where recent insider buying and strategic moves signal potential value, despite broader economic headwinds.
The Walt Disney Company reported a 5% rise in fiscal first-quarter revenue to $26 billion, fueled by its theme parks and streaming services. However, operating profit fell 9% as challenges in its traditional TV business and rising costs offset gains.
Private equity firm Exponent has halted the auction of UK accounting group Xeinadin after potential buyers refused to meet its £1bn valuation, signaling potential headwinds for deal-making in the professional services sector.
While analyst price targets often paint a rosy picture, a deeper look reveals which recommendations are backed by solid business trends and which may be overly optimistic. We examine one fintech disruptor and one industrial stalwart favored by the Street, alongside a retailer facing significant headwinds.
While recent market surges have lifted several names, discerning investors must separate fleeting hype from durable growth. We analyze two companies capitalizing on structural shifts and one whose valuation appears dangerously disconnected from fundamentals.
Nominee Kevin Warsh's desire to aggressively shrink the Federal Reserve's multi-trillion dollar holdings collides with a financial system now structurally dependent on ample liquidity, making rapid contraction a high-risk endeavor, analysts say.
While stocks priced between $10 and $50 can appear to offer an attractive balance of accessibility and maturity, their low price tags can sometimes mask underlying vulnerabilities. We examine three such companies where caution may be prudent.
While recent performance has moderated, Mercantile Bank Corporation (NASDAQ:MBWM) has rewarded long-term investors with a total shareholder return more than double the broader market's gains over the past half-decade, driven by consistent earnings growth and dividends.
The private equity giant announced a dividend increase to $1.49 per share, pushing its yield above the industry average. While future earnings projections are robust, analysts flag concerns over the current payout ratio and the firm's mixed dividend history.
While analyst price targets often paint a rosy picture, a closer look reveals a more nuanced reality. We examine one favored stock with solid fundamentals and two others where the Street's optimism may be overlooking critical risks.
In a rare break from Wall Street's typically optimistic consensus, a handful of prominent stocks are receiving bearish price targets that signal deep-seated concerns. We examine the challenges facing Deckers, MSC Industrial, and Guardant Health, and why investors might want to look elsewhere.
While OceanFirst Financial (OCFC) has kept pace with the market, analysts highlight concerns over its weak net interest income growth, modest earnings expansion, and a projected decline in tangible book value. The search for value shifts focus elsewhere.
The alternative investment manager faces heightened scrutiny as analysts project a slowdown in revenue growth ahead of Tuesday's earnings release, despite a history of recent beats.
As warnings mount over loosening lending standards in the booming private credit market, investors are scrutinizing ultra-high-yield BDC stocks. While some show signs of stress, selective opportunities may still exist for those who look beyond the headline yield.
As several stocks test their 52-week highs, we separate resilient momentum from potential mirages. We analyze one company capitalizing on long-term trends and two where caution may be warranted.
